Literature DB >> 6086633

Mitochondrial gene expression in saccharomyces cerevisiae. II. Fidelity of translation in isolated mitochondria from wild type and respiratory-deficient mutant cells.

E E McKee, J E McEwen, R O Poyton.   

Abstract

The fidelity of mitochondrial translation has been examined in isolated yeast mitochondria incubated in an optimized protein-synthesizing medium (McKee, E. E., and Poyton, R. O., (1984) J. Biol. Chem. 259, 9320-9331). These studies have revealed: that isolated mitochondria synthesize bona fide mitochondrial gene products which are identical in kind and relative amounts to those synthesized in vivo; that mitochondria isolated from both mitochondrial mit- mutants and nuclear Pet mutants, which retain the capacity for mitochondrial protein synthesis, produce a mutant pattern of mitochondrial gene products which is similar to that produced in vivo; and that isolated mitochondria synthesize up to 7% of their protein mass in vitro at a rate of about one polypeptide bond/polypeptide chain/s. These studies also reveal that isolated wild type yeast mitochondria are competent in all steps in mitochondrial translation, including initiation. Using pactamycin as a specific inhibitor of translational initiation we have demonstrated that polypeptide chain initiation continues throughout a 60-min incubation period. By using this in vitro system to calculate the stoichiometry of synthesis of the major proteins coded by yeast mitochondrial DNA we have found that the var1 polypeptide is synthesized at a level which is significantly lower than all other mitochondrial gene products and that cytochrome c oxidase subunits I, II, and III and ATPase subunit 9 are synthesized in nearly equimolar amounts. These results suggest that the synthesis of these four gene products is controlled coordinately.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6086633

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  The MSS51 gene product is required for the translation of the COX1 mRNA in yeast mitochondria.

Authors:  E Decoster; M Simon; D Hatat; G Faye
Journal:  Mol Gen Genet       Date:  1990-10

2.  A glycolytic enzyme, enolase, is recruited as a cofactor of tRNA targeting toward mitochondria in Saccharomyces cerevisiae.

Authors:  Nina Entelis; Irina Brandina; Piotr Kamenski; Igor A Krasheninnikov; Robert P Martin; Ivan Tarassov
Journal:  Genes Dev       Date:  2006-05-31       Impact factor: 11.361

3.  Rapid method for isolation and screening of cytochrome c oxidase-deficient mutants of Saccharomyces cerevisiae.

Authors:  J E McEwen; V L Cameron; R O Poyton
Journal:  J Bacteriol       Date:  1985-03       Impact factor: 3.490

4.  Mitochondrial gene expression in Saccharomyces cerevisiae. Proteolysis of nascent chains in isolated yeast mitochondria optimized for protein synthesis.

Authors:  C L Black-Schaefer; J D McCourt; R O Poyton; E E McKee
Journal:  Biochem J       Date:  1991-02-15       Impact factor: 3.857

5.  Pentamidine inhibits mitochondrial intron splicing and translation in Saccharomyces cerevisiae.

Authors:  Y Zhang; A Bell; P S Perlman; M J Leibowitz
Journal:  RNA       Date:  2000-07       Impact factor: 4.942

6.  The yeast nuclear gene MRF1 encodes a mitochondrial peptide chain release factor and cures several mitochondrial RNA splicing defects.

Authors:  H J Pel; C Maat; M Rep; L A Grivell
Journal:  Nucleic Acids Res       Date:  1992-12-11       Impact factor: 16.971

7.  Nuclear functions required for cytochrome c oxidase biogenesis in Saccharomyces cerevisiae: multiple trans-acting nuclear genes exert specific effects on expression of each of the cytochrome c oxidase subunits encoded on mitochondrial DNA.

Authors:  B Kloeckener-Gruissem; J E McEwen; R O Poyton
Journal:  Curr Genet       Date:  1987       Impact factor: 3.886

8.  MSS18, a yeast nuclear gene involved in the splicing of intron aI5 beta of the mitochondrial cox1 transcript.

Authors:  B Séraphin; M Simon; G Faye
Journal:  EMBO J       Date:  1988-05       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.